Document is current
Any future updates will be listed below
-
Authors
Selmaj, Krzysztof
Hartung, Hans-Peter
Mycko, Marcin P.
Selmaj, Igor
Cross, Anne H.
- License Information
-
More Information
Article History
Received: 3 June 2024
Revised: 12 July 2024
Accepted: 13 July 2024
First Online: 2 August 2024
Declarations
:
: KS has received personal compensation for consulting from Biogen, Celgene, GeNeuro, Merck, Novartis, Polpharma, Sanofi, Roche, and TG Therapeutics, and received research support from Merck and Roche. AHC has received fees or honoraria for consulting for Biogen, Bristol Myers Squibb, Genentech, Novartis, and Octave, and has carried out contracted research for Genentech, HPH received fees for serving on steering and data monitoring committees from BayerHealthcare, Biogen, BMS Celgene, GeNeuro, Merck, Imcyse, Novartis, Roche, TG Therapeutics, and VielaBio with approval by the Rector of Heinrich-Heine-University. MPM received compensation for lectures for Sanofi, Biogen, Merck, Serono, Novartis, Roche, Boehringer Ingelheim, and Bristol Myers Squibb. IS is not having any conflict of interest.
